Amplity's Medical Communications team offers a wide range of services with the end goal of supporting your specific needs in the pre-, peri-, and post-launch phases of your product’s lifecycle
Multichannel content deployed to your target audiences designed to maximize ROI
Amplity’s Medical Communications experts create and deploy a complete array of award-winning, data-driven scientific content to your target audience. We are supported in this effort by our Real-Time Market Intelligence (RTMI) platform which ensures we use up-to-the-minute insights when customizing your campaign. Understanding the importance of audience engagement, we place thoughtful consideration on timing, communication preferences, and channel distribution. This ensures your audience receives impactful content whenever and wherever they prefer.
Continuous customer engagement throughout a product’s lifecycle
Engagement with key experts and healthcare professionals is critical to growing your brand. Amplity’s Medical Communications team leverages our strong industry relationships to provide you with access to these audiences. Additionally, we work with you to customize a data-driven communications strategy to effectively reach your key customers directly, through scientific publications, industry/disease-specific associations, and events.
The Association for Value-Based Cancer Care (AVBCC) Summit is a prime opportunity to gain a thorough understanding of the evolution of the value equation as it relates to cancer therapies and discover how to implement, improve, and sustain your company or institution, while improving access for patients and ultimately patient care. No other meeting brings together so many key perspectives in cancer care.
40 Under 40 In Cancer
40 Under 40 in Cancer is an awards initiative to identify and recognize the contributions being made across the field of cancer by rising stars and emerging leaders under the age of 40 years.
The Cholangiocarcinoma (CCA) Summit is an opportunity to discuss the most recent advances in our understanding of the epidemiology, pathology, and management of CCA. An expert faculty and key thought leaders have been assembled to share their perspectives, to debate and discuss, and to reach consensus on a number of key issues facing healthcare providers who treat CCA. Attendees who are among the top treaters of CCA have been invited to hear viewpoints from medical and surgical oncologists, interventional radiologists, and gastroenterologists on the most pressing unmet needs in treating CCA and novel approaches to meeting those needs.
Our journals reach 90% of the US stakeholders across Oncology and Payers
200,000+
Subscribers with
2.5 million+
Touchpoints Annually Across Our Journals
Subscribers with
2.5 million+
Touchpoints Annually Across Our Journals
